Yu Jiang

Yu Jiang

Auto-generated profile, based on publicly available information

Yu Jiang

Department of Biomedical Engineering, School of Medicine and School of Engineering, University of Alabama At Birmingham, Birmingham, AL, 35294, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2024 in Journal of the American Heart Association
Verified
Journal Article
Open access
YWYongyu Wang
Yongyu Wang
YWYalin Wu
Yalin Wu
YJYu Jiang
Yu Jiang
HTHuilan Tan
Huilan Tan
BGBijay Guragain
Bijay Guragain
JZJianyi Zhang
Jianyi Zhang
Background: The proliferative capacity of cardiomyocytes in adult mammalian hearts is far too low to replace the cells that are lost to myocardial infarction. Both cardiomyocyte proliferation and myocardial regeneration can be improved via the overexpression of a constitutively active variant of YAP5SA (Yes‐associated protein, 5SA [active] mutant), but persistent overexpression of proliferation‐inducing genes could lead to hypertrophy and arrhythmia, whereas off‐target expression in fibroblasts and macrophages could increase fibrosis and inflammation. Methods and Results: Transient overexpression of YAP5SA or GFP (green fluorescent protein; control) was targeted to cardiomyocytes via our cardiomyocyte‐specific modified mRNA translation system ( YAP5SA CM‐SMRTs or GFP CM‐SMRTs, respectively). YAP5SA‐cardiomyocyte specificity was confirmed via in vitro experiments in cardiomyocytes and cardiac fibroblasts that had been differentiated from human induced‐ pluripotent stem cells and in human umbilical‐vein endothelial cells, and the regenerative potency of YAP5SA CM‐SMRTs was evaluated in a mouse myocardial infarction model. In cultured human induced‐pluripotent stem cells‐cardiomyocytes, YAP was abundantly expressed for 3 days after YAP5SA CM‐SMRTs administration and was accompanied by increases in the expression of markers for proliferation, before declining to near‐background levels after day 7, whereas GFP fluorescence remained high from days 1 to 3 after GFP CM‐SMRTs treatment and then slowly declined. GFP fluorescence was also observed in human induced‐pluripotent stem cells‐cardiac fibroblasts and human umbilical‐vein endothelial cells on day 1 after GFP CM‐SMRTs administration but declined substantially by day 3. In the mouse myocardial infarction model, echocardiographic assessments of left‐ventricular ejection fraction and fractional shortening were significantly greater, whereas infarct sizes were significantly smaller in YAP5SA CM‐SMRTs–treated mice than in vehicle‐treated control animals, and YAP5SA CM‐SMRTs appeared to promote cardiomyocyte proliferation. Conclusions: The CM‐SMRTs can be used to transiently and specifically overexpress YAP5SA in cardiomyocytes, and this treatment strategy significantly promoted cardiomyocyte proliferation and myocardial regeneration in a mouse myocardial infarction model.

11 June 2020 in Oncology Letters
Verified
Journal Article
Open access
PDF file
WYWeirong Yao
Weirong Yao
KWKaiyu Wang
Kaiyu Wang
YJYu Jiang
Yu Jiang
ZHZhufeng Huang
Zhufeng Huang
YHYiyun Huang
Yiyun Huang
JLJian Liao
Jian Liao
Our previous study reported a method of using matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry to analyze the association between abnormal fucosylation of serum glycoproteins and the progression of hepatitis B virus (HBV)‑associated hepatocellular carcinoma (HCC). In the present study, the aforementioned method was improved by focusing on fucosylated glycoproteins 20 ng/ml), the sensitivity and specificity of the models were significantly elevated to 80.73 and 87.37%, 87.16 and 90.00%, and 92.66 and 93.84%, respectively. In addition, the HBV‑HCC vs. HBV‑cirrhosis classification model was used to analyze serum samples collected from 9 patients with cirrhosis 1 year before they were diagnosed with HCC, and from 6 patients who had cirrhosis but developed no signs of HCC for the following 3 years. The model identified 7 patients (77.78%) with no significant clinical symptoms of HCC, and gave no false positive results, demonstrating that the classification models established in the present study may be useful for the early diagnosis of HCC. After isolation and purification, two proteins with differential expression were identified as isoform 1 of inter‑α‑trypsin inhibitor heavy chain 4 precursor, and thymosin β‑4‑like protein 3. These may be used as candidate markers for HCC diagnosis. Additionally, the present study indicates that defucosylation of serum glycoproteins may occur during the development and progression of HCC.

29 August 2025 in Acta Biomaterialia
Verified
Journal Article
Closed access
YWYuhua Wei
Yuhua Wei
AGAkazha Green
Akazha Green
BGBijay Guragain
Bijay Guragain
BING BOBING BO
BING BO
YJYu Jiang
Yu Jiang
Lei YeLei Ye
Lei Ye

1 January 2021 in Stem Cell Research
Verified
Journal Article
Open access
MZMin Zhou
Min Zhou
RWRui Wei
Rui Wei
YJYu Jiang
Yu Jiang
JFJian Fu
Jian Fu
YLYuqing Liu
Yuqing Liu
HTHung-Fat Tse
Hung-Fat Tse
The human transcription factor NKX2-5 plays an important role in cardiac formation and development, and thus it can be used for isolation of cardiomyocytes (CMs) differentiated from human pluripotent stem cells (hPSCs). Here, we knocked-in enhanced GFP (eGFP) and Pac (a puromycin resistant gene; PuroR) into the exon 1 coding region of NKX2-5 from a human iPSC line iPSN0003 using TALENs. The generated GIBHi002-A-2 enables us to monitor and optimize cardiac differentiation procedures via the cardiac progenitor cells (CPCs), as well as to isolate iPSC-derived CMs for drug screening.